ClinicalTrials.gg
RecruitingNCT07664514Updated Nov 20, 2026

FOCUS Pre-Post Study

An interventional study of FOCUS Guide in Surgery, sponsored by University of Utah. Recruiting at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-20.

Sponsored by University of Utah · Not applicable, Interventional, and Health services research

How we know

From the registry’s dates

  • Started Jul 2026; still recruiting 3 months later.
Updated Nov 20, 2026Now RecruitingFirst site in United States+2 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
180
Allocation
Non-randomized
Ages
18 Years and older
Sex
All
01

Study summary

The Facilitating Goal-based Conversations for Understanding Surgery (FOCUS) Guide is a communication intervention designed to support discussion and documentation of the goal for surgery during outpatient surgical consultations. The purpose of this study is to assess the efficacy of the FOCUS guide in prompting discussion of the goal for surgery.

Read the detailed description

More than 300,000 older adults undergo major non-urgent surgery annually in the United States. Older adults often prioritize independence, quality of life, and preservation of function over life prolongation when making treatment decisions. However, surgical consultations rarely include explicit discussion or documentation of the goal for surgery.

Existing surgical communication often focuses on disease-centered or "fix-it" models of care, emphasizing surgical correction of structural disease rather than discussion of outcomes that matter most to patients. As a result, patients may develop unrealistic expectations regarding surgical outcomes and may experience postoperative distress when outcomes do not align with expectations.

The Facilitating Goal-based Conversations for Understanding Surgery (FOCUS) Guide is a communication intervention designed to support discussion and documentation of the goal for surgery during outpatient surgical consultations. By facilitating explicit discussion of the goal for surgery, the intervention seeks to align surgical care with patient priorities and improve patient-centered care.

02

Conditions studied

  • Surgery

Keywords

  • Surgery
  • Goals
  • Communication guide
03

In context

Lead sponsor

University of Utah is the lead sponsor of 997 studies on the registry; 176 are open to participants now.

Of its 114 completed or terminated interventional studies of FDA-regulated products, 69 (61%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

For surgeons

1. Surgeons who have regular outpatient clinics at the University of Utah and Huntsman Cancer Institute

For patients:

  1. Age ≥65 years.
  2. Presenting for in-person outpatient consultation regarding major non-urgent surgery with an enrolled surgeon.
  3. Ability to provide .
  4. English-speaking.

Exclusion criteria

Exclusion Criteria:

For surgeons

  1. Surgeons with a predominantly pediatric practice
  2. Transplant surgeons

For patients

  1. Anticipated \<3 months.
  2. Inability to complete study procedures.
  3. Patients presenting for minor procedures or non-operative consultations.
  4. Telehealth consultation
  5. Any clinical, cognitive, communication, or logistical factor that, in the opinion of the treating surgeon or investigator, would substantially interfere with participation or completion of study procedures.
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Life expectancy

The study doctor’s estimate of how long someone is likely to live. Criteria use it so that people can stay in the study long enough for it to answer its question.

05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Non-randomized
Intervention model
Sequential assignment
Masking
Single (Outcomes assessor)
Enrollment
180 participants (estimated)

Study arms

  • No intervention
    Pre-intervention cohort

    Patients in the pre-intervention group will undergo surgical consultations according to usual care.

  • Experimental
    Post-intervention cohort

    Patients in the post-intervention group will undergo surgical consultations using the FOCUS Guide.

    Other: FOCUS Guide

Interventions

  • OtherFOCUS Guide

    The FOCUS Guide is a communication intervention designed to support discussion and documentation of the goal for surgery during outpatient surgical consultations.

06

What researchers measure

Primary outcomes

  1. Goal Discussion

    Presence or absence of explicit discussion of the goal for surgery during the surgical consultation.

    Time frame: During the surgical consultation

Secondary outcomes

  1. Goal Documentation

    Presence or absence of documentation of the goal for surgery in the surgical consultation note.

    Time frame: Immediately following the surgical consultation through 3 months

  2. Goal-Concordant Care

    Goal-concordant care will be assessed immediately following the surgical consultation using the Modified Health Outcome Prioritization Tool and associated alignment item

    Time frame: Immediately following the surgical consultation through 3 months

Other outcomes

  1. Patient-Reported Outcomes

    Changes from immediate post-visit assessment to 3 months in: * Independence * Frailty * Treatment burden * Health-related quality of life

    Time frame: Immediately following the surgical consultation through 3 months

  2. Surgeon Satisfaction Outcomes

    Surgeon-reported acceptability, feasibility, and adoption of the FOCUS Guide assessed following completion of the final study consultation.

    Time frame: 3 years

  3. Feasibility Outcomes

    Enrollment rate: defined as number of participants enrolled/eligible participants Adherence rate: defined as the number of intervention participants with a completed FOCUS Guide divided by the number of intervention participants enrolled. Retention rate: defined as the number of participants who complete 3 month follow up questionnaires/number of participants who complete immediate post-visit questionnaires

    Time frame: 3 years

  4. Exploratory Outcome: Goal Alignment Between Patient and Surgeon

    Goal alignment reflects concordance between the patient's stated treatment goal and the surgeon's stated goal for surgery.

    Time frame: Immediately following the surgical consultation through 3 months

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: Yes

No publications or documents are linked to this record.

09

Timeline

2 registry updates since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it moved

Started Jul 2026 (actual). Primary completion is estimated for May 2028, 22 months after the start.

Start moved twice since we started tracking on Sep 25, 2026: Aug 2026 → Jul 2026, last on Nov 20, 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Jun 16, 2026
First posted
Jun 24, 2026
StartActual
Jul 27, 2026was Aug 2026
Primary completionEst.
May 2028
CompletionEst.
May 2029
Last update
Nov 20, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Not yet recruiting→Recruiting
changed Nov 2, 2026
Sites
1 site added — first site in United States
Show site
  • University of Utah Hospital · Salt Lake City, United States
Nov 2, 2026
Start date
Aug 15, 2026→Jul 27, 2026
moved 2 times, Nov 2, 2026 – Nov 20, 2026
Show all 2 updates
  1. Nov 20, 2026
    Start date Aug 29, 2026→Jul 27, 2026
    + 2 other changes: verification date and design details
  2. Nov 2, 2026
    Not yet recruiting→Recruiting
    1 site added — first site in United States
    Show site
    • University of Utah Hospital · Salt Lake City, United States
    Start date Aug 15, 2026→Aug 29, 2026 (now actual)

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07664514
Lead sponsor
University of Utah
Responsible party
Jessica Cohan (Associate Professor, University of Utah) — Principal investigator
First posted
Jun 24, 2026
Start date
Jul 27, 2026
Primary completion
May 2028 (estimated)
Completion
May 2029 (estimated)
Last update
Nov 20, 2026

Study contacts

Sierra McNall, BS
Contact
Sierra.McNall@hsc.utah.edu
801-213-6543
Jordan Johnson, MPH
Contact
jordan.esplin@hsc.utah.edu
801-646-7393
Jessica Cohan, MD
principal investigator · University of Utah

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion